Association of the receptor for advanced glycation end products gene polymorphisms and circulating RAGE levels with diabetic retinopathy in the Chinese population

Journal of Diabetes Research

Volumn 2013, Issue , 2013, Pages

  Yang, Li ^a   Wu, Qunhong ^a   Li, Yuan ^a   Fan, Xiaohong ^a   Hao, Yanhua ^a   Sun, Hong ^a   Cui, Yu ^a   Han, Liyuan ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b NINGBO UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR;

ADULT; ARTICLE; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GLUCOSE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIFACTOR DIMENSIONALITY REDUCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TIME OF FLIGHT MASS SPECTROMETRY; AGED; ASIAN; BLOOD; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; STATISTICS;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DIABETIC RETINOPATHY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC;

EID: 84889005676     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2013/264579     Document Type: Article

References (33)

1. Chinese Diabetes Society, China guideline for type 2 diabetes. 2011
2. Davis M. D., Fisher M. R., Gangnon R. E., Barton F., Aiello L. M., Chew E. Y., Ferris F. L. III, Knatterud G. L., Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: early treatment diabetic retinopathy study report 18. Investigative Ophthalmology and Visual Science 1998 39 2 233 252 2-s2.0-0031917205 (Pubitemid 28093859)
3. Engerman R. L., Kern T. S., Retinopathy in animal models of diabetes. Diabetes/Metabolism Reviews 1995 11 2 109 120 2-s2.0-0029128077
4. Yamagishi S.-I., Ueda S., Matsui T., Nakamura K., Okuda S., Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy. Current Pharmaceutical Design 2008 14 10 962 968 2-s2.0-44449100222 10.2174/138161208784139729 (Pubitemid 351753283)
5. Ritthaler U., Deng Y., Zhang Y., Greten J., Abel M., Sido B., Allenberg J., Otto G., Roth H., Bierhaus A., Ziegler R., Schmidt A.-M., Waldherr R., Wahl P., Stern D. M., Nawroth P. P., Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease. American Journal of Pathology 1995 146 3 688 694 2-s2.0-0028919426
6. Soulis T., Thallas V., Youssef S., Gilbert R. E., McWilliam B. G., Murray-McIntosh R. P., Cooper M. E., Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury. Diabetologia 1997 40 6 619 628 2-s2.0-0030811664 10.1007/s001250050725 (Pubitemid 27288105)
7. Yonekura H., Yamamoto Y., Sakurai S., Petrova R. G., Abedin M. J., Li H., Yasui K., Takeuchi M., Makita Z., Takasawa S., Okamoto H., Watanabe T., Yamamoto H., Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochemical Journal 2003 370, part 3 1097 1109 2-s2.0-0037444761 10.1042/BJ20021371 (Pubitemid 36399105)
8. Yamagishi S.-I., Matsui T., Nakamura K., Inoue H., Takeuchi M., Ueda S., Fukami K., Okuda S., Imaizumi T., Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression. Microvascular Research 2008 75 1 130 134 2-s2.0-37249065845 10.1016/j.mvr.2007.05.001 (Pubitemid 350266734)
9. Malherbe P., Richards J. G., Gaillard H., Thompson A., Diener C., Schuler A., Huber G., cDNA cloning of a novel secreted isoform of the human receptor for advanced glycation end products and characterization of cells co-expressing cell-surface scavenger receptors and Swedish mutant amyloid precursor protein. Molecular Brain Research 1999 71 2 159 170 2-s2.0-0032741165 10.1016/S0169-328X(99)00174-6 (Pubitemid 29492960)
10. Pullerits R., Bokarewa M., Dahlberg L., Tarkowski A., Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis Research & Therapy 2005 7 4 R817 824 2-s2.0-21644441444
11. Basta G., Corciu A. I., Vianello A., Del Turco S., Foffa I., Navarra T., Chiappino D., Berti S., Mazzone A., Circulating soluble receptor for advanced glycation end-product levels are decreased in patients with calcific aortic valve stenosis. Atherosclerosis 2010 210 2 614 618 2-s2.0-77953232228 10.1016/j.atherosclerosis.2009.12.029
12. Goova M. T., Li J., Kislinger T., Qu W., Lu Y., Bucciarelli L. G., Nowygrod S., Wolf B. M., Caliste X., Yan S. F., Stern D. M., Schmidt A. M., Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. American Journal of Pathology 2001 159 2 513 525 2-s2.0-0034880114 (Pubitemid 32751082)
13. Hudson B. I., Stickland M. H., Futers T. S., Grant P. J., Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 2001 50 6 1505 1511 2-s2.0-0034993801 (Pubitemid 32500186)
14. Kaňková K., Záhejský J., Márová I., Mužík J., Kuhrová V., Blažková M., Znojil V., Beránek M., Vácha J., Polymorphisms in the RAGE gene influence susceptibility to diabetes-associated microvascular dermatoses in NIDDM. Journal of Diabetes and its Complications 2001 15 4 185 192 2-s2.0-0035405839 (Pubitemid 33714178)
15. American Diabetes Association, Standards of medical care in diabetes-2009. Diabetes Care 2009 32 supplement 1 S13 S61
16. Hudson B. I., Stickland M. H., Grant P. J., Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups. Diabetes 1998 47 7 1155 1157 2-s2.0-0031750332 10.2337/diabetes.47.7.1155 (Pubitemid 28294561)
17. Zhang H. M., Chen L. L., Wang L., Liao Y. F., Wu Z. H., Ye F., Xu S., Yi L. L., Association of 1704G/T and G82S polymorphisms in the receptor for advanced glycation end products gene with diabetic retinopathy in Chinese population. Journal of Endocrinological Investigation 2009 32 3 258 262 2-s2.0-67651244307
18. Liu L., Xiang K., RAGE Gly82Ser polymorphism in diabetic microangiopathy. Diabetes Care 1999 22 4 646 2-s2.0-0344142389 (Pubitemid 29153056)
19. Yoshioka K., Yoshida T., Takakura Y., Umekawa T., Kogure A., Toda H., Yoshikawa T., Relation between polymorphisms G1704T and G82S of RAGE gene and diabetic retinopathy in Japanese type 2 diabetic patients. Internal Medicine 2005 44 5 417 421 2-s2.0-21244439504 10.2169/internalmedicine.44.417 (Pubitemid 40895094)
20. Ng Z. X., Kuppusamy U. R., Poh R., Lack of association between Gly82Ser, 1704G/T and 2184A/G of RAGE gene polymorphisms and retinopathy susceptibility in Malaysian diabetic patients. Genetics and Molecular Research 2012 11 1 455 461 10.4238/2012.March.1.2
21. Balasubbu S., Sundaresan P., Rajendran A., Ramasamy K., Govindarajan G., Perumalsamy N., Hejtmancik J. F., Association analysis of nine candidate gene polymorphisms in Indian patients with type 2 diabetic retinopathy. BMC Medical Genetics 2010 11 1, article 158 2-s2.0-78149267892 10.1186/1471-2350-11-158
22. Grossin N., Wautier M.-P., Meas T., Guillausseau P.-J., Massin P., Wautier J.-L., Severity of diabetic microvascular complications is associated with a low soluble RAGE level. Diabetes and Metabolism 2008 34 4, part 1 392 395 2-s2.0-51749123983 10.1016/j.diabet.2008.04.003
23. Al-Mesallamy H. O., Hammad L. N., El-Mamoun T. A., Khalil B. M., Role of advanced glycation end product receptors in the pathogenesis of diabetic retinopathy. Journal of Diabetes and its Complications 2011 25 3 168 174 2-s2.0-79955066389 10.1016/j.jdiacomp.2010.06.005
24. Mona L. A. M., Abdel Hamid A., El-BeltagI T., Circulating soluble Receptor for advanced glycation end products and total antioxidant status in serum of diabetic patients with and without retinopathy. Australian Journal of Basic and Applied Sciences 2008 2 3 718 723
25. Jang Y., Kim J. Y., Kang S.-M., Kim J.-S., Chae J. S., Kim O. Y., Koh S. J., Lee H. C., Ahn C. W., Song Y. D., Lee J. H., Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans. Metabolism 2007 56 2 199 205 2-s2.0-33846044183 10.1016/j.metabol.2006.09.013 (Pubitemid 46074066)
26. Gaens K. H. J., Ferreira I., van der Kallen C. J. H., van Greevenbroek M. M. J., Blaak E. E., Feskens E. J. M., Dekker J. M., Nijpels G., Heine R. J., 'T Hart L. M., De Groot P. G., Stehouwer C. D. A., Schalkwijk C. G., Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels. Journal of Clinical Endocrinology and Metabolism 2009 94 12 5174 5180 2-s2.0-73249144472 10.1210/jc.2009-1067
27. Hofmann M. A., Drury S., Hudson B. I., Gleason M. R., Qu W., Lu Y., Lalla E., Chitnis S., Monteiro J., Stickland M. H., Bucciarelli L. G., Moser B., Moxley G., Itescu S., Grant P. J., Gregersen P. K., Stern D. M., Schmidt A. M., RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes and Immunity 2002 3 3 123 135 2-s2.0-0036562502 10.1038/sj.gene.6363861 (Pubitemid 38961122)
28. Schlueter C., Hauke S., Flohr A. M., Rogalla P., Bullerdiek J., Tissue-specific expression patterns of the RAGE receptor and its soluble forms-a result of regulated alternative splicing? Biochimica et Biophysica Acta 2003 1630 1 1 6 2-s2.0-0142122366 10.1016/j.bbaexp.2003.08.008 (Pubitemid 37297971)
29. Galichet A., Weibel M., Heizmann C. W., Calcium-regulated intramembrane proteolysis of the RAGE receptor. Biochemical and Biophysical Research Communications 2008 370 1 1 5 2-s2.0-41849088398 10.1016/j.bbrc.2008.02.163
30. Raucci A., Cugusi S., Antonelli A., Barabino S. M., Monti L., Bierhaus A., Reiss K., Saftig P., Bianchi M. E., A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB Journal 2008 22 10 3716 3727 2-s2.0-54049108485 10.1096/fj.08-109033
31. Osawa M., Yamamoto Y., Munesue S., Murakami N., Sakurai S., Watanabe T., Yonekura H., Uchigata Y., Iwamoto Y., Yamamoto H., De-N-glycosylation or G82S mutation of RAGE sensitizes its interaction with advanced glycation endproducts. Biochimica et Biophysica Acta 2007 1770 10 1468 1474 2-s2.0-34548542837 10.1016/j.bbagen.2007.07.003 (Pubitemid 47384994)
32. Kanková K., Márová I., Záhejský J., Mužík J., Stejskalová A., Znojil V., Vácha J., Polymorphisms 1704G/T and 2184A/G in the RAGE gene are associated with antioxidant status. Metabolism 2001 50 10 1152 1160 2-s2.0-0034760412 10.1053/meta.2001.26757 (Pubitemid 33034698)
33. Basta G., Sironi A. M., Lazzerini G., Del Turco S., Buzzigoli E., Casolaro A., Natali A., Ferrannini E., Gastaldelli A., Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein. Journal of Clinical Endocrinology and Metabolism 2006 91 11 4628 4634 2-s2.0-33751509416 10.1210/jc.2005-2559 (Pubitemid 44833448)